FeesSafety
Pluang+

Medline's selling shareholders launch 60M-share secondary offering; company plans $200M stock repurchase.

Company Fundamentals
16 Nov 2026, 13:53 WIB
GlobeNewsWire
View Source
Neutral
Medline's selling shareholders launch 60M-share secondary offering; company plans $200M stock repurchase.

Medline Inc. announced a secondary public offering of 60 million Class A common shares by selling shareholders affiliated with major investment firms. Medline itself is not selling shares and will not receive proceeds. Concurrently, Medline and its affiliate will repurchase $200 million of its Class A stock and partnership interests from these shareholders in a private transaction. This repurchase aligns with Medline's existing share buyback program and is expected to close alongside the offering, which is managed by top underwriters including Goldman Sachs and Morgan Stanley. The offering is subject to SEC registration approval.

As of Nov 16, 2026 18:41 WIB, Medline Inc. Class A common stock (MDLN) is trading at USD 39.47 on Pluang with no change in price over the past day. The stock has a market capitalization of $34.66 billion and an enterprise value of $43.70 billion. This stable trading price coincides with the announcement of a secondary offering and share repurchase program by Medline's major shareholders.

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App